Saudi Chemical CoSAU:2230 +0.86%81 Net Margin % is 5.05% as of Mar. 2026, which is 32% above its 10-year median of 3.83. GuruFocus rates SAU:2230 with a GF Score™ of 81/100 and a GF Value™ of ﷼8.54 (Fairly Valued). The stock has 3 warning signs investors should review. Among 954 Drug Manufacturers companies, Saudi Chemical Co ranks worse than 52.52% on this metric.
The historical rank and industry rank for Saudi Chemical Co's Net Margin % or its related term are showing as below:
SAU:2230'
s Net Margin % Range Over the Past 10 Years
Min: 1.11 Med: 3.83 Max: 6.31
Current: 4.89
SAU:2230's Net Margin % is ranked worse than 52.52% of 954
companies
in the Drug Manufacturers industry
Industry Median: 5.695
vs SAU:2230: 4.89
Saudi Chemical Co (SAU:2230) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Saudi Chemical Co Net Margin % Related Terms
Saudi Chemical Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Saudi Chemical Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:2230 vs ZTS, UTHR, VTRS: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saudi Chemical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saudi Chemical Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saudi Chemical Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Saudi Chemical Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saudi Chemical Co (SAU:2230) has a Net Margin % of 5.05% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Saudi Chemical Co and its competitors. This is 32% above median its historical median of 3.83. Over the past decade, Saudi Chemical Co's Net Margin % has ranged from 1.11 to 6.31. According to the industry distribution chart, Saudi Chemical Co ranks #501 out of 954 companies in the Drug Manufacturers industry, placing it in the top 52.5%.
Is Saudi Chemical Co's Net Margin % too high?
Saudi Chemical Co's current Net Margin % of 5.05% is 32% above median its 10-year median of 3.83. Over the past 10 years, this metric has ranged from a low of 1.11 to a high of 6.31. The Drug Manufacturers industry median Net Margin % is 5.70. Saudi Chemical Co's value of 5.05% is 11.3% below this industry median. Based on the distribution chart, Saudi Chemical Co ranks #501 out of 954 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Saudi Chemical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Saudi Chemical Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Saudi Chemical Co ranks #501 out of 954 companies for Net Margin %. This places Saudi Chemical Co in the lower half of its industry. The industry median Net Margin % is 5.70. Saudi Chemical Co's value of 5.05% is 11.3% below this benchmark. Historically, Saudi Chemical Co's own Net Margin % has ranged from 1.11 to 6.31 over the past decade. While the company's 10-year median is 3.83 vs. the industry median of 5.70, Saudi Chemical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.70, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saudi Chemical Co's current Net Margin % of 5.05% is 11.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Saudi Chemical Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saudi Chemical Co's current Net Margin % is 5.05%, which is 32% above median its own 10-year median of 3.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Chemical Co stock overvalued right now?
Based on GuruFocus' analysis, Saudi Chemical Co (SAU:2230) is currently considered Fairly Valued. The stock's GF Value™ is ﷼8.54, compared to a current price of ﷼8.18 — trading 4.2% below its estimated fair value. The current Net Margin % is 5.05%, which is 32% above median its 10-year median of 3.83 and 11.3% below the Drug Manufacturers industry median of 5.70. Saudi Chemical Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Saudi Chemical Co (SAU:2230), the current Net Margin % is 5.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Saudi Chemical Co (SAU:2230) Overvalued in 2026?
Based on GuruFocus' analysis, Saudi Chemical Co stock appears to be undervalued.
The current stock price of ﷼8.18 is trading 4.2% below its estimated GF Value™ of ﷼8.54.
GuruFocus considers Saudi Chemical Co to be Fairly Valued.
Key valuation signals for SAU:2230:
Net Margin %: 5.05% (32% above median its 10-year median of 3.83)
GF Value™: ﷼8.54 vs. price of ﷼8.18 (4.2% below fair value)
Industry Position: 11.3% below the Drug Manufacturers median (#501 of 954)
No single metric tells the full story. See the SAU:2230 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Saudi Chemical Co, along with its subsidiaries, is engaged in the manufacturing and distribution of explosives and their derivatives. Its other business operations include providing technical support services in explosions, wholesale and retail trading in medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools, and equipment, supplies of hospitals and medical centers, and the manufacture of ammonium nitrate. The company operates in three segments: Explosives, Medicines & medical supplies, and Production of Ammonium Nitrate. It generates the majority of its revenue from Medicines & medical supplies.
81GF Score
Get the complete analysis for SAU:2230
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:2230 has been successfully added to your 
